Biotech startup Nuritas in $3m funding

Irish biotechnology startup Nuritas has landed a $3.2m (€2.89m) investment deal courtesy of a cohort of backers from across the globe.

Singapore-based investor New Protein Capital led the funding round secured by the Dublin-based company.

Serial Silicon Valley investor Ali Partovi, who has served as a strategic advisor to Dropbox, Zappos, and Facebook, is another of those investing in Nuritas.

The company is a major innovator in the health industry, uncovering health benefits of natural sources such as food.

The company is able to find and harness the peptides which carry these benefits ten times faster than the prohibitive norm and at a fraction of the cost.

“I was told this was impossible and I decided not to listen,” said Nuritas founder Nora Khaldi.

“I built a team who believe in what we do and together we made it happen. We have discovered and patented some incredible life-changing ingredients and we will discover many more.”

Nuritas chief executive Emmet Browne welcomed the investment, saying it will allow the company to accelerate the achievement of its goals.

“We are delighted to collaborate with such like-minded and visionary investors to help us accelerate the discovery revolution that we have already started,” Mr Browne said.

“We share the same vision of dramatically improving life through combining cutting edge technology with intellect.

“With this investment we will become even better at speedily unlocking nature’s life-changing secrets that have remained hidden until now and as a result, improve global health.”



Lifestyle

What’s better for your health – sleeping naked or in pyjamas?

Fixing leeks in the cold snap

How some home truths can help save the planet

Wish List: Some delightfully eclectic products we need in our lives

More From The Irish Examiner